FdaApplication
ANDA 211505
Identifiers
- fda_app_no: ANDA211505
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2020-11-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DIVALPROEX SODIUM | DIVALPROEX SODIUM | EQ 125MG VALPROIC ACID | CAPSULE, DELAYED REL PELLETS;ORAL |
1 product